Market Cap | ₹11,587Cr |
ROE | 17.24% |
P/E Ratio(TTM) | 23.38 |
EPS(TTM) | 40.40 |
P/B Ratio | 4.11 |
Dividend Yield | 0.53% |
Industry P/E | 39.57 |
Book Value | 229.65 |
Debt to Equity | 0.02 |
Face Value | 2 |
Parent Organisation | Alivus Life Sciences |
Managing Director | Dr. Yasir Rawjee |
NSE Symbol | ALIVUS |
FUND NAME | AUM(%) |
---|---|
Quant Flexi Cap Fund Direct Growth | 1.60% |
Tata Small Cap Fund Direct Growth | 0.71% |
Union ELSS Tax Saver Fund Direct Growth | 0.58% |
Union Flexi Cap Fund Direct Growth | 0.57% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.61 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.39 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.44 | ||
Wockhardt | NA (0.00%) | -188.59 |